p53 and E2f: partners in life and death

Shirley Polager,Doron Ginsberg
DOI: https://doi.org/10.1038/nrc2718
IF: 78.5
2009-10-01
Nature Reviews Cancer
Abstract:Key PointsThere is extensive crosstalk between the Rb–E2f and MDM2–p53 pathways, and specifically between the transcription factors E2F1 and p53, which influences vital cellular decisions.The abundance and activity of both p53 and E2f are often controlled by the same cancer-associated stimuli. Their common regulators include checkpoint kinases and acetyltransferases, MDM2 and the CDKN2A locus.Deregulated E2f, which is often present in human tumours, constitutes an oncogenic stress that activates p53. Specifically, E2f indirectly affects the level and activity of p53 by upregulating the expression of many proteins that stabilize and activate p53. Examples include ARF, ataxia telangiectasia mutated and PIN1.E2f and p53 cooperate in restricting tumorigenesis by inducing cell death. Their cooperation in apoptosis is attributed to the ability of E2F1 to activate p53. In addition, they activate many pro-apoptotic genes that may cooperate in apoptosis.Protein complexes that contain Rb family members and repressor E2fs mediate p53-induced growth arrest and senescence; the latter is an important in vivo mechanism that contributes to protection against cancer.
oncology
What problem does this paper attempt to address?